Navigation Links
Neurocrine Biosciences Reports First Quarter 2013 Results
Date:5/2/2013

riod in 2012.  This increase was primarily a result of higher external clinical development expenses related to the ongoing Phase IIb studies of the Company's VMAT2 inhibitor, NBI-98854. General and administrative expenses decreased from $3.7 million in the first quarter of 2012 to $3.4 million for the first quarter of 2013, primarily due to lower professional services costs and continued cost mitigation efforts.

Pipeline HighlightsElagolix UpdateAbbVie is currently conducting the initial Phase III study of elagolix for endometriosis, the Violet Petal Study. The study is a 24-week, multinational, randomized, double-blind, placebo-controlled study designed to evaluate the safety and efficacy of elagolix in 875 women, age 18 to 49, with moderate to severe endometriosis-associated pain. Approximately 160 sites in the United States, Puerto Rico and Canada are conducting this study.

During March 2013, AbbVie initiated a Phase IIb study of elagolix in uterine fibroids. This study is assessing uterine blood loss in 280 women with heavy uterine bleeding due to uterine fibroids.

VMAT2 UpdateThe Company is currently conducting two Phase IIb studies of its VMAT2 inhibitor, NBI-98854.

The Kinect Study is a 120 subject, placebo-controlled, double-blind, parallel-design, multiple-dose, 12-week study assessing six-week dosing of NBI-98854 against placebo, followed by six weeks of open-label treatment with NBI-98854 in tardive dyskinesia patients with underlying schizophrenia or schizoaffective disorder. The primary endpoint is the Abnormal Involuntary Movement Scale (AIMS) at the end of the first six weeks of dosing. The study will also incorporate a capsule formulation of NBI-98854. Top-line data from the placebo-controlled portion of this study is expected in the third quarter of 2013.

The Kinect 2 Study is a 90 subject, placebo-controlled, double-blind,
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
2. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
3. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
4. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
5. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
6. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
7. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
8. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
9. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
11. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... CHAPEL HILL, N.C. , Jan. 23, 2015 For ... organizations are in dealing with payers. Likewise, the importance of ... payers - will only continue to grow as payer formularies ... patients access therapies. At the same time, managed ...
(Date:1/23/2015)... Partnership to Fight Chronic Disease (PFCD) released a public opinion poll ... new study analyzing the impact of increased cost sharing on patient ... to educate policy makers and the public on the costs of ... how the Iowa healthcare exchange could be ...
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced the ... the compounding, packaging and distributing of its naltrexone tablets.  The ... United States . KRS Global is ... tablets in various strengths for individual patients in response to ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the American ... effort to further promote visibility and adoption of the top ... AMA journals available via its subscription services, EBSCO will now ... , Long known as both a subscription agency and ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Corporation,(Nasdaq: AIRM ) will report financial results for ... of the market on Wednesday, March 12,2008. The Company ... at 4:15 p.m. Eastern to discuss these results., ... 396-5640,(domestic) or (706) 643-0580 (international) or by accessing the ...
... March 5 Natalie Waples,an Ottawa based and ... Board: NTNI) http://www.naturalnutritioninc.com ,subsidiary InterACTIVE Nutrition International ... Championships (height class "E") held at,the Arnolds Sports ... ), The event was held from ...
... an Antarctic fish species that adopts a winter survival ... the journal PLoS ONE, the online journal from the ... (BAS) and the University of Birmingham reveal, for the ... puts itself on ice to survive the long Antarctic ...
... Dental Network of,America Inc. (DNoA) announced today the ... The new program is now being,utilized by Health Care ... Blue Cross and Blue Shield Plans in Illinois, New ... Blue Cross and Blue Shield,Association., Research continues to ...
... March 4 Secretary of Health,Dr. Calvin B. ... workers at,Edinboro University to discuss Governor Edward G. ... hundreds of thousands of uninsured adults,through his "Cover ... is critical to help prevent disease,successfully manage chronic ...
... N.J., March 4 ,Cathedral Healthcare System Inc. has ... interest, to settle allegations that it defrauded the ... The settlement resolves allegations that the Newark, N.J.-based,hospital ... order,to obtain enhanced reimbursement from the federal health ...
Cached Medicine News:Health News:Natural Nutrition's Spokesperson and Athlete Natalie Waples Wins 2008 Arnold Amateur Figure Championship 2Health News:Hibernation-like behavior in Antarctic fish -- on ice for winter 2Health News:Dental Network of America Inc. Launches Integrated Medical-Dental Health Program 2Health News:Dental Network of America Inc. Launches Integrated Medical-Dental Health Program 3Health News:Health Secretary Stops in Erie County to Call for Health Insurance for all Pennsylvanians 2Health News:Cathedral Healthcare System to Pay U.S. $5.3 Million to Resolve Allegations Involving Inflated Charges to Obtain Higher Medicare Reimbursement 2
... The GlucoWatch G2 Biographer is intended ... glucose levels in adults (aged 18 and ... with diabetes. Parents should supervise the use ... The G2 Biographer is intended to supplement, ...
... Worlds First Solid-State Three-Color Photocoagulator.,Retinal physicians ... purchase over 3,000 Lumenis multi-color photocoagulators.,For ... practice, the Novus Varia integrates green, ... a single, compact system that supports ...
... For complete capsular protection over 360°. ... secures the eyelet positioning under the ... contact with capsule and easier implantation. ... high myopia, uveitis, diabetic, sonulo-capsular laxity, ...
... is a device designed for permanent implantation ... removal surgery. It provides secondary capsular bag ... The CTR is a uniplanar, 270-degree, semi-circle ... absorbing polymethylmethacrylate (PMMA) with one manipulation eyelet ...
Medicine Products: